SWTX

SpringWorks Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD46.99

+0.01 (+0.02%)

Company Profile

CEO

Saqib Islam

IPO Date

2019-09-13

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Market Metrics

Open

$46.99

Prev. Close

$46.99

Day Low

$46.99

Day High

$46.99

52W Low

$28.21

52W High

$62.00

Market Cap

$3.54B

Volume

5.01M

News SentimentBullish

Articles

Avg Positive

32.1%

Avg Negative

1.3%

Avg Neutral

66.4%

News Feed

SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Mirdametinib, Extending Patent Protection Into 2041

GlobeNewsWire·7/20/2021·↑ positive

7 Top-Rated Pharmaceutical Companies to Invest In for July

InvestorPlace·7/9/2021·↑ positive

SpringWorks Therapeutics Reveals Updated Interim Mirdametinib Data In Rare Genetic Disorder